Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

SBP, platelet count (PLT), total bilirubin, tg (P = 0.014), vitamin D, vitamin B12, and alcohol consumption showed no statistically significant differences among groups.

Source: Baseline characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study utilized National Health and Nutrition Examination Survey (NHANES) data from 1998 to 2020 cycles to investigate the association between ANLR and DR in diabetic patients with external validation in an independent study.

Source: Abstract.

Diabetic patients were consecutively enrolled from the Department of Ophthalmology between January 2023 and December 2023, comprising diabetic patients with detailed retinal examination and laboratory data.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Albumin-to-neutrophil-lymphocyte ratio: a novel dual-pathway biomarker for diabetic retinopathy risk assessment

Cross-sectional study · Frontiers in Endocrinology · 2025

Original publication title

Albumin-to-neutrophil-lymphocyte ratio: a novel dual-pathway biomarker for diabetic retinopathy risk assessment

Chongyang She; Yong Tao; Shuo Yang

Copyright © 2025 She, Tao and Yang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

ANLR demonstrates a significant inverse association with DR risk and severity in diabetic patients, exhibiting a nonlinear dose-response relationship validated across independent populations. As an easily obtainable biomarker integrating inflammatory and nutritional status, ANLR may serve as a valuable tool for DR risk stratification and early identification of high-risk patients, potentially guiding personalized prevention strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Diabetic retinopathy (DR) represents a leading cause of blindness globally, with conventional risk factors inadequately explaining disease occurrence and progression. The albumin-to-neutrophil-lymphocyte ratio (ANLR), a composite biomarker integrating nutritional and inflammatory status, has shown predictive value in various diabetic complications but its relationship with DR remains unexplored.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional study utilized National Health and Nutrition Examination Survey (NHANES) data from 1998 to 2020 cycles to investigate the association between ANLR and DR in diabetic patients with external validation in an independent study. ANLR was calculated as serum albumin divided by neutrophil-to-lymphocyte ratio. DR status was assessed through self-reporting in NHANES and ophthalmologic examination in the validation study. Survey-weighted generalized linear models were employed to evaluate associations, with participants stratified into quartiles based on ANLR values. Restricted cubic spline analysis examined nonlinear relationships, and subgroup analyses explored effect modification.

Source: Methods

Abstract: Results

A total of 6,279 diabetic participants were included in the NHANES analysis and 212 in the external validation study. After multivariable adjustment, higher ANLR quartiles demonstrated significantly reduced DR risk compared to Q1: Q2 (OR = 0.59, 95%CI: 0.38-0.91, P = 0.018), Q3 (OR = 0.73, 95%CI: 0.47-1.13, P = 0.164, non-significant), and Q4 (OR = 0.57, 95%CI: 0.36-0.90, P = 0.017). A significant dose-response relationship was observed (P for trend=0.044). Restricted cubic spline analysis revealed a nonlinear L-shaped association (P for nonlinearity=0.033), with rapid risk reduction at ANLR values <20 and plateau thereafter.

The external validation study confirmed these findings with stronger associations (Q4 vs Q1: OR = 0.31, P = 0.010; P for trend=0.005) and demonstrated progressively lower ANLR levels across DR severity stages (no DR, NPDR, PDR; P for trend=0.017). Subgroup analyses identified significant interactions for sex, BMI, apolipoprotein B, and HDL-C, with stronger protective effects observed in females, individuals with higher BMI, and those with favorable lipid profiles.

Source: Results

Abstract: Conclusion

ANLR demonstrates a significant inverse association with DR risk and severity in diabetic patients, exhibiting a nonlinear dose-response relationship validated across independent populations. As an easily obtainable biomarker integrating inflammatory and nutritional status, ANLR may serve as a valuable tool for DR risk stratification and early identification of high-risk patients, potentially guiding personalized prevention strategies.

Source: Conclusion
Authors’ abstract

Background

Diabetic retinopathy (DR) represents a leading cause of blindness globally, with conventional risk factors inadequately explaining disease occurrence and progression. The albumin-to-neutrophil-lymphocyte ratio (ANLR), a composite biomarker integrating nutritional and inflammatory status, has shown predictive value in various diabetic complications but its relationship with DR remains unexplored.

Methods

This cross-sectional study utilized National Health and Nutrition Examination Survey (NHANES) data from 1998 to 2020 cycles to investigate the association between ANLR and DR in diabetic patients with external validation in an independent study. ANLR was calculated as serum albumin divided by neutrophil-to-lymphocyte ratio. DR status was assessed through self-reporting in NHANES and ophthalmologic examination in the validation study. Survey-weighted generalized linear models were employed to evaluate associations, with participants stratified into quartiles based on ANLR values. Restricted cubic spline analysis examined nonlinear relationships, and subgroup analyses explored effect modification.

Results

A total of 6,279 diabetic participants were included in the NHANES analysis and 212 in the external validation study. After multivariable adjustment, higher ANLR quartiles demonstrated significantly reduced DR risk compared to Q1: Q2 (OR = 0.59, 95%CI: 0.38-0.91, P = 0.018), Q3 (OR = 0.73, 95%CI: 0.47-1.13, P = 0.164, non-significant), and Q4 (OR = 0.57, 95%CI: 0.36-0.90, P = 0.017). A significant dose-response relationship was observed (P for trend=0.044). Restricted cubic spline analysis revealed a nonlinear L-shaped association (P for nonlinearity=0.033), with rapid risk reduction at ANLR values <20 and plateau thereafter.

The external validation study confirmed these findings with stronger associations (Q4 vs Q1: OR = 0.31, P = 0.010; P for trend=0.005) and demonstrated progressively lower ANLR levels across DR severity stages (no DR, NPDR, PDR; P for trend=0.017). Subgroup analyses identified significant interactions for sex, BMI, apolipoprotein B, and HDL-C, with stronger protective effects observed in females, individuals with higher BMI, and those with favorable lipid profiles.

Conclusion

ANLR demonstrates a significant inverse association with DR risk and severity in diabetic patients, exhibiting a nonlinear dose-response relationship validated across independent populations. As an easily obtainable biomarker integrating inflammatory and nutritional status, ANLR may serve as a valuable tool for DR risk stratification and early identification of high-risk patients, potentially guiding personalized prevention strategies.

Publication and source details

Original title: Albumin-to-neutrophil-lymphocyte ratio: a novel dual-pathway biomarker for diabetic retinopathy risk assessment

Chongyang She; Yong Tao; Shuo Yang

Frontiers in Endocrinology · 2025

* Correspondence: Yong Tao, taoyong@bjcyh.com; Shuo Yang, yangshuo001@126.comCopyright © 2025 She, Tao and Yang.2025She, Tao and Yanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare financial support was received for the research and/or publication of this article. This study was funded by the Youth Project of National Natural Science Foundation of China (62206185).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:40:00.619215+00:00

DOI: 10.3389/fendo.2025.1687507 · PMC12660086